Pharmaceutical

EC expands indication approval for Merck’s Ebola vaccine

The European Commission granted expanded indication approval for Merck’s Ebola vaccine, Ervebo, to include children aged one year or above.

Sep 9, 2023 - 20:00
EC expands indication approval for Merck’s Ebola vaccine
The European Commission granted expanded indication approval for Merck’s Ebola vaccine, Ervebo, to include children aged one year or above.
Read the original article

Tags:

Previous Article

NICE recommends Lilly’s tirzepatide to treat T2D

Next Article

Biocytogen and Myricx Bio partner for development of ADCs

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Astellas withdraws lawsuit after evading Medicare drug price negotiations

STAT+: Astellas withdraws lawsuit after evading Medicar...

Sep 6, 2023

STAT+: FDA OKs — but doesn’t require — a non-cancer-causing chemical for sterilizing devices

STAT+: FDA OKs — but doesn’t require — a non-cancer-cau...

Jan 24, 2024

Cure Genetics and Frametact seek gene cures for neurological ailments

Cure Genetics and Frametact seek gene cures for neurolo...

Sep 15, 2023